SCHEMBL5316933

SCHEMBL5316933

N#Cc1ccc(CNC(=O)CN2CC3CN(CCCOc4ccccc4)CC(C2)O3)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.47
KCNA5 P22460 1/20 0.47
HTR1A P08908 8/20 0.45
DRD2 P14416 8/20 0.45
HTR7 P34969 5/20 0.45
HTR6 P50406 5/20 0.45
MEN1 O00255 3/20 0.45
HTR2A P28223 1/20 0.45
HTR5A P47898 1/20 0.45
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
CACNA1B Q00975 4/20 0.44
CACNA1H O95180 2/20 0.43
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319103 0.96 KCNH2 (0.49) KCNH2KCNA5HTR1ADRD2HTR7
SCHEMBL5314900 0.91 KCNA5 (0.55) KCNH2KCNA5HTR1ADRD2HTR7
SCHEMBL5315724 0.91 KCNH2 (0.56) KCNH2HTR1ADRD2HTR7HTR6
SCHEMBL5314598 0.90 KCNH2 (0.53) KCNH2KCNA5HTR1ADRD2HTR7
SCHEMBL5318090 0.90 KCNH2 (0.52) KCNH2KCNA5MEN1HRH2HRH1
SCHEMBL5315427 0.89 MEN1 (0.47) KCNH2KCNA5HTR1ADRD2HTR7
SCHEMBL5314570 0.89 HTR1A (0.48) HTR1ADRD2HTR7HTR6MEN1
SCHEMBL5314840 0.88 HTR1A (0.53) KCNH2HTR1ADRD2HTR7HTR6
SCHEMBL5315301 0.88 KCNH2 (0.48) KCNH2HTR1ADRD2HTR7HTR6
SCHEMBL5317348 0.88 FAAH (0.46) KCNH2MEN1HTR2AHRH3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007069986-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2007-06-21 WO claimed
WO-2007069986-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2007-06-21 WO disclosed